A Study to Evaluate the Effectiveness and Tolerance of Two Acne Treatments on Subjects With Mild to Moderate Acne. (TIGER)
A Multi-Center, Evaluator Blinded, Randomized Clinical Study to Evaluate the Efficacy and Tolerance of Two Acne Treatments on Subjects With Mild to Moderate Acne Vulgaris
Sponsor: Johnson & Johnson Consumer and Personal Products Worldwide
Listed as NCT02698436, this NA trial focuses on Acne Vulgaris and remains completed. Sponsored by Johnson & Johnson Consumer and Personal Products Worldwide, it has been updated 9 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Feb 2020 — Jan 2021 [monthly]
Completed NA
-
Jun 2018 — Feb 2020 [monthly]
Completed NA
▶ Show 4 earlier versions
-
Feb 2018 — Jun 2018 [monthly]
Completed NA
-
May 2017 — Feb 2018 [monthly]
Completed NA
Status: Withheld → Completed
-
Feb 2017 — May 2017 [monthly]
Withheld NA
-
Jan 2017 — Feb 2017 [monthly]
Withheld NA
First recorded
Mar 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Johnson & Johnson Consumer and Personal Products Worldwide
For direct contact, visit the study record on ClinicalTrials.gov .